{
    "2019-04-09": [
        [
            {
                "time": "",
                "original_text": "沃森生物2019年第一季度盈利3800万元-4150万元",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "2019年",
                        "第一季度",
                        "盈利",
                        "3800万元",
                        "4150万元"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "沃森生物：预计一季度净利润同比增长60.00%-75.00%",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "一季度",
                        "净利润",
                        "同比增长",
                        "60.00%",
                        "75.00%"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "沃森生物：一季度净利预增60%-75%",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "一季度",
                        "净利",
                        "预增",
                        "60%",
                        "75%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}